Novotech Wins Contract for Komipharm Coronavirus Covid-19 Trial in South Korea

Published on: 

Applied Clinical Trials

Asia-Pacific biotech CRO Novotech has been selected for the Komipharm International clinical trial of Panaphix as a potential treatment for coronavirus - Covid-19. Panaphix is a cytokine storm inhibitor that restrains the overproduction of immune cells and their activating compounds, cytokines.

For more information, click here.